News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Palvella is the recipient of an FDA Orphan Product Grant up to $2.6 million
Oct 5, 2024, 08:59

Palvella is the recipient of an FDA Orphan Product Grant up to $2.6 million

Palvella Therapeutics shared on LinkedIn:

“Today, we announced Palvella is the recipient of an FDA Orphan Product Grant up to $2.6 million which will support the advancement of our ongoing Phase 3 single-arm baseline-controlled trial in microcystic lymphatic malformations.

This underscores our belief in the potential of QTORIN™ rapamycin which has also received FDA Breakthrough Therapy, Fast Track, and Orphan Designations for this serious, rare and chronically debilitating genetic disease.

Learn more here.”

Source: Palvella Therapeutics/LinkedIn

cancer FDA genetic disease microcystic lymphatic malformations OncoDaily Oncology Palvella Therapeutics QTORIN Rapamycin
Special Coverage
Blog
Dec 2, 2024, 10:22
Tejas Patil: The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in non-small cell lung cancer
Blog
Dec 2, 2024, 10:01
Women, Power, and Cancer: my latest interview with ecancer - Ophira Ginsburg
Blog
Dec 2, 2024, 09:57
Michael Shusterman: GI Oncology standard regimen doses remain too high for many real world patients
Positive
Dec 2, 2024, 09:46
Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
Blog
Dec 2, 2024, 09:07
Support Children Battling Cancer and their Parents with The Goodwill Foundation - Onco Intelligence
Blog
Dec 2, 2024, 09:04
How can mpMRI change management of patients with NMIBC or MIBC?
Blog
Dec 2, 2024, 08:15
Nikhil Vojjala: Excited to win the Michigan state ACP Doctors dilemma championship
Insight
Dec 2, 2024, 08:12
Mattia Rediti: Our work describing HER2-positive Breast Cancer heterogeneity is out
Insight
Dec 2, 2024, 08:01
Enrique Soto: Our systematic review on the use of wearable technologies in older adults with Cancer
Insight
Dec 2, 2024, 07:43
Bishoy M. Faltas: We are looking for Postdocs Interested in studying Cancer Evolution
Blog
Dec 2, 2024, 07:40
Caitlin Delaney: I am launching my fundraiser for off-label treatments which will hopefully extend my life
Opinion
Dec 1, 2024, 22:10
Mike Thompson: Myeloma/Plasma Cell Dyscrasia Draft Table Update